
We will absolutely need to continue our endeavors to evaluate reliable predictive biomarkers for both targeted drugs and immunotherapeutic agents to achieve a truly personalized melanoma therapy with the maximal clinical benefit.

Your AI-Trained Oncology Knowledge Connection!


Published: May 15th 2013 | Updated: